Search in:   Search
spacer

Latvia Pharmaceuticals & Healthcare Report Q2 2013

Published by Business Monitor International on Mar 4, 2013 , 92 pages
PDF - Download Now with 3 Quarterly Updates format - Delivered by download


Description
BMI View: We view Latvia's pharmaceutical market as one of the least promising in the Emerging Europe region, from a longer-term point of view. Despite a largely favourable business and operating environment, pharmaceutical companies are looking at a market in which annual per capita expenditure on medicines is still below the US$200 mark. Strategies for cost-containment in public-sector healthcare, such as the possible use of joint procurement systems with its peer Baltic states, will also have an impact on this low-value market that serves a population of well under 2.5mn.



REPORT TOOLSarrow
Share This Report
Request More Information
Printable Brochure
ORDERINGarrow
Ordering reports couldn't be easier. Select the license for your needs, click Order Now, and complete our streamlined checkout process. We accept major credit cards, wire/bank transfers, and checks.

MC, Visa, AMEX, Diners, Discovery, JCB

PUBLISHERarrow
Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.\n\nBMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including Daily Alerts, monthly regional Insights, and in-depth quarterly Country Forecast Reports.
Publisher Details


Privacy Policy | Terms of Use | Sitemap

Copyright © 2012 Fast Market Research, Inc.